People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eterna Therapeutics Inc. | — | Biotechnology | Series A | $53.1M | $26.5M | 2009 |
| RippleNami, Inc. | — | Other Technology | Pre-Seed | $550K | $16.9M | 2016 |
Kendra Berger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kendra Berger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Angel | 1 | 5 |
| Andrew Jackson | 1 | 4 |
| Charles Cherington | 1 | 3 |
| Richard W. Wagner | 1 | 3 |
| Gregory Fiore | 1 | 3 |
| Heather B. Redman | 1 | 2 |
| Jeff Berg | 1 | 2 |
| James Bristol | 1 | 2 |
| STEVE MITGANG | 1 | 2 |
| Erin S. Enright | 1 | 2 |
| PAUL YANOVER | 1 | 1 |
| TONY UPHOFF | 1 | 1 |
| Peter Cicala | 1 | 1 |
| Sandra Gurrola | 1 | 1 |
| Philip Gahn | 1 | 1 |
| Sanjeev Luther | 1 | 1 |
| Elena Ratner | 1 | 1 |
| Dorothy Clarke | 1 | 1 |
| Brant Binder | 1 | 1 |
| Nicholas J. Singer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.